Go to the market
10
s
Transcript of Go to the market
s
Outline1. Biopharmaceutical market and
opportunities2. Brand positioning3. ProFAX value added4. Go to the market strategy
Biopharmaceutical marketBig growth prospects [1]:
• Global revenues of $163 billion • Annual growth rate of more of 8%
[1] Otto, R., Santagostino, A., & Schrader, U. (2014). Rapid growth in biopharma: Challenges and opportunities. From Sci. to Oper. Quest. Choices Strateg. Success Biopharma, 1-21.
Market opportunities• Pharmaceutical companies are shifting their R&D and
sourcing focus to biopharma.
• Increasing understanding of the interaction between drugs and the genetic makeup of patients.
Combined with low-cost genetic profiling:
• Improvement of treatments;• Acceleration of the outcomes of clinical trials;• Cost of drug development reduced.
Market issueCompanies are slowed down by the high computational needing of the algorithms:
• high times of execution;• high power consumption.
aims at solving this problem!
Brand positioning (1)Positioning
• Acceleration of algorithms in biopharmaceutical industry by exploiting FPGA programmability.
Promise
• A speed-up in the execution time. • An optimization of performance over power consumption
ratio. • Our support would be crucial to enhance the productivity of
such firms.
Personas• Their algorithms, no matter the specific field of application. As
our algorithm is provided just as an example.
Personality• We are two students from NECST Lab at Politecnico di Milano
with a drive for computer science. • We believe that our team, thanks to a multi-field approach, can
give a valuable contribution to bioinformatics research.
Product• We offer hardware acceleration services in order to help
companies maximizing their performance over power consumption ratio.
Brand positioning (2)
ProFAX added value• Biopharmaceutical algorithms are complex• Close biologists collaboration & computer science experts
[1]• Modeling and statistics
The composition of our team allows for this type of successful collaboration.
[1] Otto, R., Santagostino, A., & Schrader, U. (2014). Rapid growth in biopharma: Challenges and opportunities. From Sci. to Oper. Quest. Choices Strateg. Success Biopharma, 1-21.
Heterogeneity of competences
Go to market strategy1. We aim at creating a prototype to illustrate our project
features to prospect customers.
2. We will look for future customers and make them aware of ProFAX potentialities, which have been recognized by well known international conferences.
RAW ConferenceIPDPS 2016
Chicago, IL | MAY 23-24
University Demonstration
DAC 2016Austin, TX |JUNE 5-9
Thanks for your attention
Lorenzo Di TucciGiulia Guidi
[email protected]@mail.polimi.it
Follow us on : https://www.facebook.com/profaxnecstlab/
Follow us on : https://twitter.com/ProFAX_NECST
Follow us on : http://www.slideshare.net/ProFAX
